Trial record 1 of 2 for:    western regional Kundranda
Previous Study | Return to List | Next Study

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2013 by Western Regional Medical Center
Sponsor:
Information provided by (Responsible Party):
Madappa Kundranda, MD, Western Regional Medical Center
ClinicalTrials.gov Identifier:
NCT01851174
First received: February 15, 2013
Last updated: May 9, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2015
  Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)